Enliven Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $503k | 25k | 20.47 |
| 2025-06-30 | $426k | 21k | 20.06 |
| 2025-03-31 | $423k | 22k | 19.68 |
| 2024-12-31 | $489k | 22k | 22.50 |
| 2024-09-30 | $523k | 21k | 25.54 |
| 2024-06-30 | $478k | 21k | 23.37 |
| 2023-12-31 | $171k | 12k | 13.84 |
| 2023-09-30 | $169k | 12k | 13.66 |
| 2023-06-30 | $252k | 12k | 20.41 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors